Michael S. Isakoff

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score–Matched Survival Outcome Comparisons”.

Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score–Matched Survival Outcome Comparisons

Journal of Clinical Oncology(2024)10.1200/jco.22.02875

N/A

0.637DataRank · unranked

69 citations

William Ferguson, Jacqueline M. Kraveka, Genevieve Bergendahl, Thomas Clinch, Elizabeth Lorenzi +12 more

Immunosuppressive Tumor Microenvironment of Osteosarcoma

Cancers(2025)10.3390/cancers17132117

N/A

0.503DataRank · unranked

19 citations

Jianting Sheng, Patrick Kwok Shing Ng, Jeffrey M. Harder, Parveen Kumar, Ju Young Ahn +23 more

Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421): A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10508

N/A

0.442DataRank · unranked

18 citations

Mark Krailo, Allen Buxton, Paul R. Hutson, J. Wade Davis, Katherine A. Janeway +3 more

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children’s Oncology Group

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2885

N/A

0.104DataRank · unranked

1 citations

Alexander J. Chou, Allen Buxton, Joel M. Reid, Michael S. Isakoff, Lisa M. Kopp +12 more

Immunosuppressive tumor microenvironment of osteosarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.01.565008

N/A

0DataRank · unranked

2 citations

Jianting Sheng, Patrick Kwok‐Shing Ng, Jeffrey M. Harder, Parveen Kumar, Ju Young Ahn +23 more

Data from Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion

(2023)10.1158/0008-5472.c.6513853.v1

N/A

0DataRank · unranked

1 citations

William P.D. Hendricks, Abhinav B. Nagulapally, Jacqueline M. Kraveka, William S. Ferguson, Valerie I. Brown +34 more

An evolutionary framework for treating pediatric sarcomas

Cancer(2020)10.1002/cncr.32777

N/A

0DataRank · unranked

51 citations

Jonathan Metts, Mariyah Pressley, Brooke L. Fridley, Masanori Hayashi, Michael S. Isakoff +9 more

Data from A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

(2023)10.1158/1078-0432.c.6532608.v1

N/A

0DataRank · unranked

0 citations

Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch +11 more

Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement

Journal of the National Comprehensive Cancer Network(2024)10.6004/jnccn.2024.7063

N/A

0DataRank · unranked

9 citations

Alyaa Al‐Ibraheemi, Jessica L. Davis, C. Matthew Hawkins, Brian T. Craig, Roshni Dasgupta +26 more

Cytokine Profiling of Children, Adolescents, and Young Adults Newly Diagnosed with Sarcomas Demonstrates the Role of IL-1β in Osteosarcoma Metastasis

Cancers(2025)10.3390/cancers17183009

N/A

0DataRank · unranked

1 citations

William Kandalaft, Aakash Mahant Mahant, Jessica Crimella, Sydney Hakim, Xiao Peng +4 more

Data from A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

(2023)10.1158/1078-0432.c.6532608

N/A

0DataRank · unranked

0 citations

Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch +11 more

Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion

Cancer Research(2021)10.1158/0008-5472.can-21-1033

N/A

0DataRank · unranked

17 citations

William P.D. Hendricks, Abhinav B. Nagulapally, Jacqueline M. Kraveka, William S. Ferguson, Valerie I. Brown +34 more

Updated outcomes for patients with completely resected pulmonary recurrent osteosarcoma: A report from the Children’s Oncology Group.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10023

N/A

0DataRank · unranked

3 citations

Mark Krailo, Ruxu Han, Allen Buxton, Damon R. Reed, Richard Görlick +5 more

A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1169

N/A

0DataRank · unranked

32 citations

Dan G. Duda, Genevieve Bergendahl, David H. Ebb, Matija Snuderl, Theodore W. Laetsch +11 more